Glucose Et Chlorure De Sodium B.Braun (Sodium Chloride, Glucose)

Glucose Et Chlorure De Sodium B.Braun is indicated for clinical situations where fluid and electrolyte balance need to be restored. It is commonly employed in hospital settings for patients requiring intravenous hydration and metabolic support.

• Replacement of lost body fluids during dehydration or blood loss
• Replenishment of sodium and chloride electrolytes
• Prevention or treatment of hypoglycemia in at‑risk patients
• Peri‑operative hydration to maintain circulatory volume
• Support of metabolic needs during critical illness

Adverse reactions to Glucose Et Chlorure De Sodium B.Braun are generally infrequent but can vary in severity. Monitoring during infusion helps identify and manage potential side effects.

Common

• Mild local irritation at the infusion site
• Transient nausea or vomiting
• Slight increase in blood glucose levels
• Temporary electrolyte imbalance (e.g., mild hypernatremia)

Serious

• Severe allergic reaction (anaphylaxis)
• Significant hyperglycemia requiring medical intervention
• Rapid fluid overload leading to pulmonary edema

When administering Glucose Et Chlorure De Sodium B.Braun, clinicians should consider patient‑specific factors and monitor for complications. Proper assessment and vigilance are essential.

• Verify patient’s electrolyte and glucose status before infusion
• Adjust infusion rate in patients with cardiac or renal impairment
• Use caution in patients with known hypersensitivity to sodium chloride or glucose
• Monitor blood glucose and serum electrolytes during and after administration
• Avoid rapid infusion in neonates and infants
• Ensure aseptic technique to prevent infection at the injection site

Glucose Et Chlorure De Sodium B.Braun may interact with other medications, affecting fluid balance, electrolyte levels, or glucose control. Review concurrent therapies before use.

Avoid

• Concurrent administration of high‑dose diuretics that may exacerbate electrolyte loss
• Use with hypertonic glucose solutions that could cause severe hyperglycemia

Use with caution

• Co‑administration with insulin or oral hypoglycemics (monitor glucose)
• Concurrent use of other intravenous electrolytes (adjust dosing)
• Patients receiving blood products (monitor for electrolyte shifts)
• Medications that affect renal function (e.g., ACE inhibitors, NSAIDs)